Literature DB >> 21482850

Orlistat and acute kidney injury: an analysis of 953 patients.

Matthew A Weir, Michael M Beyea, Tara Gomes, David N Juurlink, Muhammad Mamdani, Peter G Blake, Ron Wald, Amit X Garg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21482850     DOI： 10.1001/archinternmed.2011.103

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  21 in total

1.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

2.  Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.

Authors:  Mai H Trac; Eric McArthur; Racquel Jandoc; Stephanie N Dixon; Danielle M Nash; Daniel G Hackam; Amit X Garg
Journal:  CMAJ       Date:  2016-02-22       Impact factor: 8.262

3.  Rebuttal: Should family physicians prescribe medication for obesity? NO.

Authors:  Elizabeth Shaw
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

4.  Les médecins de famille devraient-ils prescrire des médicaments contre l'obésité? NON.

Authors:  Elizabeth Shaw
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

5. 

Authors:  Elizabeth Shaw
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

6.  Should family physicians prescribe medication for obesity? NO.

Authors:  Elizabeth Shaw
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

Review 7.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

Review 8.  Does orlistat cause acute kidney injury?

Authors:  Michael M Beyea; Amit X Garg; Matthew A Weir
Journal:  Ther Adv Drug Saf       Date:  2012-04

Review 9.  Benefit-risk assessment of orlistat in the treatment of obesity.

Authors:  Priya Sumithran; Joseph Proietto
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

10.  Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss.

Authors:  Sankar D Navaneethan
Journal:  Circulation       Date:  2019-01-15       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.